Evaluating the effectiveness of a new drug combination in the eradication therapy for duodenal ulcer

Abstract

Peptic ulcer (PU) remains the most common disease of the gastrointestinal tract. There is evidence of the pathogenic role of Helicobacter pylori (HP) in this process. PU associated with HP is an indication for eradication therapy.

Keywords

• язвенная болезнь двенадцатиперстной кишки
• эрадикация нр-инфекции
• препарат ланцид кит
• stomach ulcer